Oral / IV
    • Mechanism of Action
    • Inhibits voltage-gated sodium channels, preventing propagation of action potentials and thus suppressing seizure activity.
    • Pharmacology
    • Non-linear pharmacokinetics – small dose changes can result in large changes in plasma concentration.
    • Co-administration with valproate results in increased serum concentrations of phenytoin

Clinical Use

    • Indications
    • Generalised tonic-clonic seizures
    • Status epilepticus (IV)
    • Adverse Effects
    • Nausea / vomiting
    • Hirsutism
    • CNS disturbances – drowsiness, tremor, dysarthria, diplopia
    • Purple glove syndrome (IV) – distal limb discolouration, pain and swelling
    • Anticonvulsant hypersensitivity syndrome (prolonged admin) – fever, rash, lymphadenopathy, hepatitis, myositis
    • Monitoring
    • Plasma concentration should be monitored in order to ensure therapeutic effect.
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge